David S Jevsevar1, Peter B Shores, Kyle Mullen, Danielle M Schulte, Gregory A Brown, Deborah S Cummins. 1. From the Department of Orthopaedics, Dartmouth-Hitchcock Medical Center, Lebanon, NH (Dr. Jevsevar), American Academy of Orthopaedic Surgeons, Rosemont, IL (Mr. Shores, Mr. Mullen, Ms. Schulte, and Dr. Cummins), and Franciscan Orthopedic Associates, Tacoma, WA (Dr. Brown).
Abstract
INTRODUCTION: Knee osteoarthritis (KOA) is a significant health problem with lifetime risk of development estimated to be 45%. Effective nonsurgical treatments are needed for the management of symptoms. METHODS: We designed a network meta-analysis to determine clinically relevant effectiveness of nonsteroidal anti-inflammatory drugs, acetaminophen, intra-articular (IA) corticosteroids, IA platelet-rich plasma, and IA hyaluronic acid compared with each other as well as with oral and IA placebos. We used PubMed, EMBASE, and Cochrane Central Register of Controlled Trials to perform a systematic search of KOA treatments with no date limits and last search on October 7, 2015. Article inclusion criteria considered the following: target population, randomized controlled study design, English language, human subjects, treatments and outcomes of interest, ≥30 patients per group, and consistent follow-up. Using the best available evidence, two abstractors independently extracted pain and function data at or near the most common follow-up time. RESULTS: For pain, all active treatments showed significance over oral placebo, with IA corticosteroids having the largest magnitude of effect and significant difference only over IA placebo. For function, no IA treatments showed significance compared with either placebo, and naproxen was the only treatment showing clinical significance compared with oral placebo. Cumulative probabilities showed naproxen to be the most effective individual treatment, and when combined with IA corticosteroids, it is the most probable to improve pain and function. DISCUSSION: Naproxen ranked most effective among conservative treatments of KOA and should be considered when treating pain and function because of its relative safety and low cost. The best available evidence was analyzed, but there were instances of inconsistency in the design and duration among articles, potentially affecting uniform data inclusion.
INTRODUCTION:Knee osteoarthritis (KOA) is a significant health problem with lifetime risk of development estimated to be 45%. Effective nonsurgical treatments are needed for the management of symptoms. METHODS: We designed a network meta-analysis to determine clinically relevant effectiveness of nonsteroidal anti-inflammatory drugs, acetaminophen, intra-articular (IA) corticosteroids, IA platelet-rich plasma, and IA hyaluronic acid compared with each other as well as with oral and IA placebos. We used PubMed, EMBASE, and Cochrane Central Register of Controlled Trials to perform a systematic search of KOA treatments with no date limits and last search on October 7, 2015. Article inclusion criteria considered the following: target population, randomized controlled study design, English language, human subjects, treatments and outcomes of interest, ≥30 patients per group, and consistent follow-up. Using the best available evidence, two abstractors independently extracted pain and function data at or near the most common follow-up time. RESULTS: For pain, all active treatments showed significance over oral placebo, with IA corticosteroids having the largest magnitude of effect and significant difference only over IA placebo. For function, no IA treatments showed significance compared with either placebo, and naproxen was the only treatment showing clinical significance compared with oral placebo. Cumulative probabilities showed naproxen to be the most effective individual treatment, and when combined with IA corticosteroids, it is the most probable to improve pain and function. DISCUSSION: Naproxen ranked most effective among conservative treatments of KOA and should be considered when treating pain and function because of its relative safety and low cost. The best available evidence was analyzed, but there were instances of inconsistency in the design and duration among articles, potentially affecting uniform data inclusion.
Authors: Andrew Concoff; Jeffrey Rosen; Freddie Fu; Mohit Bhandari; Kevin Boyer; Jon Karlsson; Thomas A Einhorn; Emil Schemitsch Journal: JBJS Rev Date: 2019-08
Authors: Mark Phillips; Mohit Bhandari; John Grant; Asheesh Bedi; Thomas Trojian; Aaron Johnson; Emil Schemitsch Journal: Orthop J Sports Med Date: 2021-08-31
Authors: Javad Javadi Hedayatabad; Amir R Kachooei; Negar Taher Chaharjouy; Niloufar Vaziri; Hassan Mehrad-Majd; Maryam Emadzadeh; Mansour Abolghasemian; Mohammad H Ebrahimzadeh Journal: Arch Bone Jt Surg Date: 2020-05
Authors: Mohamed Ahmed Said Ahmed; Emad Samuel Boles Saweeres; Nasr Awad Abdelkader; Salwa Fadl Abdelmajeed; Ahmed Roshdy Fares Journal: Indian J Orthop Date: 2019 Nov-Dec Impact factor: 1.251
Authors: Andrade Carlos Augusto Ferreira de; Isabel Ruguê Genov; Sara Regina Neto Pereira; Joao Mauricio Barreto; Max Rogério Freitas Ramos; Eduardo Costa Freitas da Silva; Liszt Palmeira de Oliveira Journal: Medicine (Baltimore) Date: 2020-09-11 Impact factor: 1.817